Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 23 Oct 2024 for Inhibikase Therapeutics, Inc., €1.8M. Read the official filing
Filing timeline
BuySaleRoberto Bellini
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
1
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Roberto Bellini: trading record in brief
Only one filing by Roberto Bellini is known so far (23 October 2024): an open-market purchase, €1.8M, in Inhibikase Therapeutics, Inc. That is too little to draw conclusions. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Roberto Bellini
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
1,460,000 shares@ US$1.37100.0% of flowCommon StockSEC:0000950170-24-116785:0
Canonical exit: 19 Jan 2025 (T+90)
1 of 1 declaration
